All 2D-BioPAD partners recently came together for a workshop organised by Evnia. The main goal was to review and validate the project’s preliminary hazard analysis.
During the meeting, partners worked together to identify possible risks and agree on suitable control measures, making sure everything is in line with IVDR requirements.
Once the analysis is finalised, the relevant information will be included in the prospective clinical study protocol. This workshop marked an important step in ensuring the project moves forward safely and in compliance with regulations.
